Article info
PDFClinical science
Spironolactone versus observation in the treatment of acute central serous chorioretinopathy
- Correspondence to Dr Songtao Yuan, Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; yuansongtao{at}vip.sina.com and Weizhong Ge, Department of Ophthalmology, Yixing People’s Hospital, Yixing 214200, China; staff326{at}yxph.com
Citation
Spironolactone versus observation in the treatment of acute central serous chorioretinopathy
Publication history
- Received July 24, 2017
- Revised September 13, 2017
- Accepted September 30, 2017
- First published October 31, 2017.
Online issue publication
September 29, 2018
Article Versions
- Previous version (29 September 2018).
- Previous version (29 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.